1. 877. North American Phase 3/3b Experience with Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes. (4th December 2021) Authors: Taiwo, Babafemi O; Tan, Darrell; Patel, Parul; Teichner, Paula; Polli, Joseph; Garside, Louise; D'Amico, Ronald; Talarico, Christine L; Van Solingen-Ristea, Rodica; Baugh, Bryan; Spreen, William; Aboud, Michael; Bosse, Matthew Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 885. Pregnancy Outcomes and Pharmacokinetics in Pregnant Women Living with HIV Exposed to Long-Acting Cabotegravir and Rilpivirine in Clinical Trials. (4th December 2021) Authors: Patel, Parul; Ford, Susan L; Baker, Mark; Meyer, Claudia; Garside, Louise; D'Amico, Ronald; Van Solingen-Ristea, Rodica; Crauwels, Herta; Polli, Joseph; Seal, Ciara; Thiagarajah, Shanker; Birmingham, Eileen; Spreen, William; Baugh, Bryan; Bosse, Matthew; Vannappagari, Vani Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S534 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study. (January 2016) Authors: van Lunzen, Jan; Antinori, Andrea; Cohen, Calvin J.; Arribas, José R.; Wohl, David A.; Rieger, Armin; Rachlis, Anita; Bloch, Mark; Segal-Maurer, Sorana; Garner, Will; Porter, Danielle; Bosse, Matthew; Piontkowsky, David; Chuck, Susan K.; De-Oertel, Shampa Journal: AIDS Issue: Volume 30:Number 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗